{"DataElement":{"publicId":"10216346","version":"1","preferredName":"Diffuse Large B-Cell Lymphoma LymphGen Algorithm Genetic Subtype Category","preferredDefinition":"The response indicating the large B-cell lymphoma genetic subtype identified using the LymphGen algorithm.","longName":"10216310v1.00:10182816v1.00","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"10216310","version":"1","preferredName":"Diffuse Large B-Cell Lymphoma LymphGen Algorithm Genetic Subtype","preferredDefinition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.:An algorithm designed to use the prevalence of genetic features in cases of diffuse large B-cell lymphoma to estimate the likelihood that a feature is associated with a genetic subtype and combines these likelihoods to calculate a probability that a tumor belongs to one of seven genetic subtypes._Having to do with information that is passed from parents to offspring through genes in sperm and egg cells._A group forming a type within a larger type.","longName":"2478319v1.00:10216309v1.00","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"2478319","version":"1","preferredName":"Diffuse Large B-Cell Lymphoma","preferredDefinition":"This non-Hodgkin's lymphoma is characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin's lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) -- 2003","longName":"C8851","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Large B-Cell Lymphoma","conceptCode":"C8851","definition":"A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes.  It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases.  Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma.  Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11E01CB8-267E-253F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-04-20","modifiedBy":"ONEDATA","dateModified":"2006-04-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"10216309","version":"1","preferredName":"LymphGen Algorithm Genetic Subtype","preferredDefinition":"An algorithm designed to use the prevalence of genetic features in cases of diffuse large B-cell lymphoma to estimate the likelihood that a feature is associated with a genetic subtype and combines these likelihoods to calculate a probability that a tumor belongs to one of seven genetic subtypes._Having to do with information that is passed from parents to offspring through genes in sperm and egg cells._A group forming a type within a larger type.","longName":"C187191:C17938:C25696","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"LymphGen Algorithm","conceptCode":"C187191","definition":"An algorithm designed to use the prevalence of genetic features in cases of diffuse large B-cell lymphoma to estimate the likelihood that a feature is associated with a genetic subtype and combines these likelihoods to calculate a probability that a tumor belongs to one of seven genetic subtypes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Genetic","conceptCode":"C17938","definition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED6273D-0807-221E-E053-731AD00A8FB3","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-16","modifiedBy":"GDEEN","dateModified":"2022-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED6273D-0808-221E-E053-731AD00A8FB3","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-16","modifiedBy":"GDEEN","dateModified":"2022-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10182816","version":"1","preferredName":"Diffuse Large B Cell Lymphoma Genetic Subtype Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"10182816v1.00","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"BN2","valueDescription":null,"ValueMeaning":{"publicId":"10182817","version":"1","preferredName":"BN2 Diffuse Large B-Cell Lymphoma","longName":"10182817v1.00","preferredDefinition":"A diffuse large B-cell lymphoma molecular subtype characterized by the presence of BCL6 gene fusions and NOTCH2 gene mutations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BN2 Diffuse Large B-Cell Lymphoma","conceptCode":"C148395","definition":"A diffuse large B-cell lymphoma molecular subtype characterized by the presence of BCL6 gene fusions and NOTCH2 gene mutations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED70430-7887-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED70430-788D-2FBF-E053-731AD00A19BF","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","deletedIndicator":"No"},{"value":"EZB","valueDescription":null,"ValueMeaning":{"publicId":"10182818","version":"1","preferredName":"EZB Diffuse Large B-Cell Lymphoma","longName":"10182818v1.00","preferredDefinition":"A diffuse large B-cell lymphoma molecular subtype characterized by the presence of EZH2 gene mutations and BCL2 gene translocations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EZB Diffuse Large B-Cell Lymphoma","conceptCode":"C148398","definition":"A diffuse large B-cell lymphoma molecular subtype characterized by the presence of EZH2 gene mutations and BCL2 gene translocations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED70430-7888-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED70430-788E-2FBF-E053-731AD00A19BF","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","deletedIndicator":"No"},{"value":"N1","valueDescription":null,"ValueMeaning":{"publicId":"10182820","version":"1","preferredName":"N1 Diffuse Large B-Cell Lymphoma","longName":"10182820v1.00","preferredDefinition":"A diffuse large B-cell lymphoma molecular subtype characterized by the presence of NOTCH1 gene mutations. Patients who belong in this subtype have an inferior outcome. (NEJM 2018; 378: 1396-407)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1 Diffuse Large B-Cell Lymphoma","conceptCode":"C148396","definition":"A diffuse large B-cell lymphoma molecular subtype characterized by the presence of NOTCH1 gene mutations. Patients who belong in this subtype have an inferior outcome. (NEJM 2018; 378: 1396-407)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED70430-788A-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED70430-788F-2FBF-E053-731AD00A19BF","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","deletedIndicator":"No"},{"value":"EZB-MYC+","valueDescription":null,"ValueMeaning":{"publicId":"10182821","version":"1","preferredName":"MYC Positive EZB Diffuse Large B-Cell Lymphoma","longName":"10182821v1.00","preferredDefinition":"Indicates that MYC expression has been detected in a sample._A diffuse large B-cell lymphoma molecular subtype characterized by the presence of EZH2 gene mutations and BCL2 gene translocations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MYC Positive","conceptCode":"C131061","definition":"Indicates that MYC expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EZB Diffuse Large B-Cell Lymphoma","conceptCode":"C148398","definition":"A diffuse large B-cell lymphoma molecular subtype characterized by the presence of EZH2 gene mutations and BCL2 gene translocations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED70430-788B-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED70430-7890-2FBF-E053-731AD00A19BF","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","deletedIndicator":"No"},{"value":"EZB-MYC-","valueDescription":null,"ValueMeaning":{"publicId":"10182822","version":"1","preferredName":"MYC Negative EZB Diffuse Large B-Cell Lymphoma","longName":"10182822v1.00","preferredDefinition":"An indication that MYC expression has not been detected in a sample._A diffuse large B-cell lymphoma molecular subtype characterized by the presence of EZH2 gene mutations and BCL2 gene translocations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MYC Negative","conceptCode":"C162511","definition":"An indication that MYC expression has not been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EZB Diffuse Large B-Cell Lymphoma","conceptCode":"C148398","definition":"A diffuse large B-cell lymphoma molecular subtype characterized by the presence of EZH2 gene mutations and BCL2 gene translocations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED70430-788C-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED70430-7891-2FBF-E053-731AD00A19BF","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED70430-7892-2FBF-E053-731AD00A19BF","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","deletedIndicator":"No"},{"value":"MCD","valueDescription":null,"ValueMeaning":{"publicId":"10182819","version":"1","preferredName":"MCD Diffuse Large B-Cell Lymphoma","longName":"10182819v1.00","preferredDefinition":"A diffuse large B-cell lymphoma molecular subtype characterized by the co-occurrence of MYD88 and CD79B gene mutations. Patients who belong in this subtype have an inferior outcome. (NEJM 2018; 378: 1396-407)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MCD Diffuse Large B-Cell Lymphoma","conceptCode":"C148394","definition":"A diffuse large B-cell lymphoma molecular subtype characterized by the co-occurrence of MYD88 and CD79B gene mutations. Patients who belong in this subtype have an inferior outcome. (NEJM 2018; 378: 1396-407)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED70430-7889-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DED70430-7893-2FBF-E053-731AD00A19BF","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-12","deletedIndicator":"No"},{"value":"ST2","valueDescription":null,"ValueMeaning":{"publicId":"10381972","version":"1","preferredName":"ST2 Diffuse Large B-Cell Lymphoma","longName":"10381972v1.00","preferredDefinition":"A genetic subtype of diffuse large B-cell lymphoma characterized by SGK1 and TET2 gene mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ST2 Diffuse Large B-Cell Lymphoma","conceptCode":"C187445","definition":"A genetic subtype of diffuse large B-cell lymphoma characterized by SGK1 and TET2 gene mutations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-22EA-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-26","modifiedBy":"GDEEN","dateModified":"2022-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC1DD82-22EC-2FB8-E053-731AD00AE15F","beginDate":"2022-05-26","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-26","modifiedBy":"GDEEN","dateModified":"2022-05-26","deletedIndicator":"No"},{"value":"A53","valueDescription":null,"ValueMeaning":{"publicId":"10381973","version":"1","preferredName":"A53 Diffuse Large B-Cell Lymphoma","longName":"10381973v1.00","preferredDefinition":"A genetic subtype of diffuse large B-cell lymphoma characterized by TP53 gene mutations and deletions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"A53 Diffuse Large B-Cell Lymphoma","conceptCode":"C187447","definition":"A genetic subtype of diffuse large B-cell lymphoma characterized by TP53 gene mutations and deletions that is often accompanied by aneuploidy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-22EB-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-26","modifiedBy":"GDEEN","dateModified":"2022-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC1DD82-22ED-2FB8-E053-731AD00AE15F","beginDate":"2022-05-26","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-26","modifiedBy":"GDEEN","dateModified":"2022-05-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DED70430-7886-2FBF-E053-731AD00A19BF","latestVersionIndicator":"Yes","beginDate":"2022-05-12","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-12","modifiedBy":"GDEEN","dateModified":"2022-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"LymphGen Subtype","type":"Preferred Question Text","description":"LymphGen Subtype","url":null,"context":"OCG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DF253FFF-E4B1-4E37-E053-731AD00A0E79","latestVersionIndicator":"Yes","beginDate":"2022-05-16","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-05-16","modifiedBy":"GDEEN","dateModified":"2022-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}